We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

4 hedge funds and large institutions have $11.2M invested in Cyteir Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

71% less capital invested

Capital invested by funds: $38.9M → $11.2M (-$27.7M)

89% less funds holding

Funds holding: 38 → 4 (-34)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 35

Holders
4
Holders Change
-34
Holders Change %
-89.47%
% of All Funds
0.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
1
Reduced
–
Closed
35
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
+$1.25M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$81.4K

Top Sellers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
-$9.19M
2
GF
Gabelli Funds
New York
-$3.37M
3
AFM
Anson Funds Management
Texas
-$3.33M
4
GCIA
Gabelli & Co Investment Advisers
New York
-$3.12M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BML Capital Management
Indiana
$11M +$1.25M +404,045 +12%
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$77K +$81.4K +26,319 New
BFO
3
Boston Family Office
Massachusetts
$73K – – –
LC
4
Lindbrook Capital
California
$6.04K – – –
NM
5
Newtyn Management
New York
– -$9.19M -3,021,500 Closed
GF
6
Gabelli Funds
New York
– -$3.37M -1,110,050 Closed
AFM
7
Anson Funds Management
Texas
– -$3.33M -1,096,422 Closed
GCIA
8
Gabelli & Co Investment Advisers
New York
– -$3.12M -1,026,000 Closed
Vanguard Group
9
Vanguard Group
Pennsylvania
– -$2.09M -687,391 Closed
Millennium Management
10
Millennium Management
New York
– -$1.37M -451,980 Closed
Walleye Capital
11
Walleye Capital
New York
– -$1.3M -427,037 Closed
LCM
12
Laurion Capital Management
New York
– -$961K -316,201 Closed
BI
13
Bulldog Investors
New Jersey
– -$608K -200,000 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$541K -177,930 Closed
AC
15
Aldebaran Capital
Indiana
– -$437K -143,739 Closed
RC
16
RBF Capital
California
– -$357K -117,295 Closed
BlackRock
17
BlackRock
New York
– -$278K -91,578 Closed
Bank of America
18
Bank of America
North Carolina
– -$271K -89,304 Closed
Northern Trust
19
Northern Trust
Illinois
– -$208K -68,283 Closed
Squarepoint
20
Squarepoint
New York
– -$204K -67,219 Closed
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
– -$204K -66,300 Closed
PFCS
22
Pale Fire Capital SE
Czech Republic
– -$175K -57,597 Closed
CL
23
CSS LLC
Illinois
– -$168K -55,359 Closed
State Street
24
State Street
Massachusetts
– -$140K -46,153 Closed
Jane Street
25
Jane Street
New York
– -$126K -41,602 Closed
1
2

CYT Hedge Fund Activity: Q1 2024 in Review

4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q1 2024, worth a combined $11.2M — down 71% from $38.9M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CYT and 1 opened new positions — a net loss of 34 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was BML Capital Management, adding an estimated $1.25M. The largest seller was Newtyn Management, exiting entirely with an estimated $9.19M sold.

  • 4 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q1 2024, down from 38 in Q4 2023.
  • Funds reported $11.2M of Cyteir Therapeutics, Inc. Common Stock stock for Q1 2024, down 71% quarter-over-quarter.
  • 1 fund opened new Cyteir Therapeutics, Inc. Common Stock positions in Q1 2024 and 35 closed out, a net change of -34 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q1 2024 was BML Capital Management, an estimated $1.25M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q1 2024 was Newtyn Management, an estimated $9.19M sold.

Based on aggregated 13F filings for Q1 2024.